Plunging Cholesterol: Reducing Major Cardiovascular Events in At-Risk Patients

Plunging Cholesterol: Reducing Major Cardiovascular Events in At-Risk Patients is organized by Prime Education, LLC.

Release Date: June 12, 2019
Expiration Date: June 11, 2020

Intended Audience:
Physicians, Nurse Practitioners, Physician Assistants, Nurses, and Pharmacists

Accreditation:
Continuing Education Credits:
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement
PRIME designates this Enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity

Physician Assistant Accreditation Statement
This program has been reviewed and is approved for a maximum of 1.0 hour of AAPA Category I CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.

Nurse Practitioner Accreditation Statement
This activity is approved for 1.0 contact hour of continuing education (which includes .2 hour of pharmacology) by the American Association of Nurse Practitioners. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Pharmacist Accreditation Statement
This curriculum has been approved for 1.0 contact hour (0.1 CEUs) by PRIME. PRIME is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Pharmacist Accreditation Statement

Nurse Accreditation Statement
PRIME® designates this activity for 1.0 contact hour.

 

Description:
Breakthrough advances in lipid treatment and cardiovascular risk reduction are poised to transform outcomes for patients with hypercholesterolemia and cardiovascular disease, yet many patients remain undertreated. In this video activity, hear real-world patient perspectives on managing difficult-to-treat hypercholesterolemia, and gain insights from renowned lipid experts on applying the latest evidence from cardiovascular outcomes trials and novel treatment approaches to reduce the risk for cardiovascular events in hard-to-treat patients with hypercholesterolemia.